Skip to main content
. Author manuscript; available in PMC: 2013 Sep 15.
Published in final edited form as: Clin Cancer Res. 2012 Jul 12;18(18):5081–5089. doi: 10.1158/1078-0432.CCR-12-0078

Figure 1.

Figure 1

Post-infusion plasma profiles of free (blue) and bound (red) aflibercept for subjects treated with a 1-hour infusion of 2 (short dashed lines), 2.5 (long-dashed lines) or 3 (solid lines) mg/kg aflibercept.